Published ahead of print on May 30, 2003, doi:10.1165/rcmb.2003-0028OC
© 2003 American Thoracic Society DOI: 10.1165/rcmb.2003-0028OC Human ADAM33 Messenger RNA Expression Profile and Post-Transcriptional RegulationDepartments of Allergy and Human Genomics, Schering-Plough Research Institute, Kenilworth, New Jersey; and Canji Inc., San Diego, California Address correspondence to: Shelby P. Umland, Ph.D., Schering-Plough Research Institute, 2015 Galloping Hill Road, K15-1-1700, Kenilworth, NJ 07033. E-mail: shelby.umland{at}spcorp.com
We examined transcript expression and post-transcriptional regulation of human ADAM33, a recently identified asthma gene. A detailed messenger RNA (mRNA) expression profile was obtained using Northern, reverse transcription polymerase chain reaction, and in situ hybridization analyses. ADAM33 mRNA was expressed significantly in smooth musclecontaining organs, minimally in immune organs and hematopoietic cells, and highly in repairing duodenal granulation tissue. Expression was seen in asthmatic subepithelial fibroblasts and smooth muscle but not in respiratory epithelium. In all tissues, transcripts of
Abbreviations: antibody, Ab a distintegrin and metalloprotease, ADAM bronchial smooth muscle cells, BSMC complimentary DNA, cDNA Chinese hamster kidney cells, CHO-K1 cycle threshold, Ct epidermal growth factor, EGF human embryonic kidney cells, HEK a tag of six histidine residues, his messenger RNA, mRNA normal human lung fibroblasts, NHLF in situ hybridization, ISH polymerase chain reaction, PCR recombinant adenovirus, rAd reverse transcription PCR, RT-PCR Tris-buffered saline, TBS TBS with 0.1% Tween 20, TBS-T tumor necrosis factor, TNF untranslated region, UTR
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||